Jane Street
ABCL icon

Jane Street’s AbCellera Biologics ABCL Stock Holding History

Jane Street’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Buy
166,100
+80,500
+94% +$393K ﹤0.01% 5978
2026
Q1 		$299K Buy
85,600
+55,000
+180% +$198K ﹤0.01% 9250
2025
Q4 		$105K Buy
30,600
+20,100
+191% +$89.7K ﹤0.01% 10166
2025
Q3 		$52.8K Buy
+10,500
New +$46.3K ﹤0.01% 10335
2024
Q3 		– Sell
-72,400
Closed -$214K – 9479
2024
Q2 		$214K Sell
72,400
-1,900
-3% -$7.19K ﹤0.01% 8284
2024
Q1 		$337K Sell
74,300
-2,300
-3% -$11.7K ﹤0.01% 7369
2023
Q4 		$437K Buy
76,600
+65,100
+566% +$302K ﹤0.01% 6991
2023
Q3 		$52.9K Sell
11,500
-400
-3% -$2.43K ﹤0.01% 8138
2023
Q2 		$76.9K Sell
11,900
-4,400
-27% -$30K ﹤0.01% 8100
2023
Q1 		$123K Buy
16,300
+400
+3% +$3.63K ﹤0.01% 8116
2022
Q4 		$161K Sell
15,900
-102,100
-87% -$1.18M ﹤0.01% 7823
2022
Q3 		$1.17M Sell
118,000
-58,300
-33% -$640K ﹤0.01% 5139
2022
Q2 		$1.88M Buy
176,300
+53,700
+44% +$455K ﹤0.01% 4288
2022
Q1 		$1.2M Sell
122,600
-91,500
-43% -$866K ﹤0.01% 5766
2021
Q4 		$3.06M Buy
214,100
+38,000
+22% +$577K ﹤0.01% 3648
2021
Q3 		$3.53M Buy
176,100
+84,100
+91% +$1.49M ﹤0.01% 3355
2021
Q2 		$2.02M Buy
+92,000
New +$2.54M ﹤0.01% 4317

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Jane Street's ABCL Position: Q2 2026 in Review

Jane Street reduced its AbCellera Biologics (ABCL) stake by 77% in Q2 2026, selling an estimated $3.19M and leaving 195,262 shares worth $1.53M. The position accounts for ﹤0.01% of the portfolio, ranked #5647.

Jane Street first reported a position in ABCL in Q4 2020 and has held it in 21 quarters since. The position peaked at $5.49M in Q4 2021. 151 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.

  • Jane Street held 195,262 shares of AbCellera Biologics worth $1.53M as of Q2 2026.
  • Jane Street sold 652,621 AbCellera Biologics shares in Q2 2026, an estimated $3.19M.
  • AbCellera Biologics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #5647 holding.
  • Jane Street first reported a position in AbCellera Biologics in Q4 2020 and has held it in 21 quarters since.
  • Jane Street's AbCellera Biologics position peaked at $5.49M in Q4 2021.
  • 151 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.